Table 2. Relationship between acetyl-histones 3 and 4 expression and the clinicopathological features of glioma.

Clinicopathological features	acetyl-histone 3 expression							acetyl-histone 4 expression
	n	-	+	++	+++	PR(%)	p	n	-	+	++	+++	PR(%)	p
Sex
Male	111	9	14	31	57	91.9	0.229	111	13	19	33	46	88.3	0.014*
Female	75	0	8	25	42	100		76	1	10	23	42	98.7
Age (years)
<44	83	4	8	25	46	95.2	0.482	85	7	18	30	30	91.8	0.004*
≥44	102	5	14	31	52	95.1		101	7	11	25	58	93.1
Pathological grading
I-II	81	3	7	31	40	96.3	0.260	84	7	14	34	29	91.7	0.112
III-IV	51	5	10	12	24	90.2		47	6	6	8	27	87.2
Pathological classification
astrocytoma	102	8	12	33	49	92.2	0.384	103	11	20	33	39	89.3	0.004*
anaplastic  astrocytoma	32	1	4	7	20	96.9		31	2	3	7	19	93.5
glioblastoma	26	0	5	8	13	100		25	0	3	7	15	100

^*p< 0.05; PR, positive rate